Vaccinia virus immunization provides lifelong protection against smallpox, but the mechanisms of this exquisite protection are unknown. We used polychromatic flow cytometry to characterize the functional and phenotypic profile of CD8+ T cells induced by vaccinia virus immunization in a comparative vaccine trial of modified vaccinia virus Ankara (MVA) versus Dryvax immunization in which protection was assessed against subsequent Dryvax challenge. Vaccinia virus–specific CD8+ T cells induced by both MVA and Dryvax were highly polyfunctional; they degranulated and produced interferon γ, interleukin 2, macrophage inflammatory protein 1β, and tumor necrosis factor α after antigenic stimulation. Responding CD8+ T cells exhibited an unusual phenotype (CD45RO−CD27intermediate). The unique phenotype and high degree of polyfunctionality induced by vaccinia virus also extended to inserted HIV gene products of recombinant NYVAC. This quality of the CD8+ T cell response may be at least partially responsible for the profound efficacy of these vaccines in protection against smallpox and serves as a benchmark against which other vaccines can be evaluated.
Skip Nav Destination
Article navigation
11 June 2007
Article|
May 29 2007
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses
Melissa L. Precopio,
Melissa L. Precopio
1Immunology Laboratory
Search for other works by this author on:
Michael R. Betts,
Michael R. Betts
6Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
Search for other works by this author on:
Janie Parrino,
Janie Parrino
2Viral Pathogenesis Laboratory
Search for other works by this author on:
David A. Price,
David A. Price
3Human Immunology Section
7Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, England, UK
Search for other works by this author on:
Emma Gostick,
Emma Gostick
7Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, England, UK
Search for other works by this author on:
David R. Ambrozak,
David R. Ambrozak
1Immunology Laboratory
Search for other works by this author on:
Daniel C. Douek,
Daniel C. Douek
3Human Immunology Section
Search for other works by this author on:
Alexandre Harari,
Alexandre Harari
8Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland
Search for other works by this author on:
Giuseppe Pantaleo,
Giuseppe Pantaleo
8Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland
Search for other works by this author on:
Barney S. Graham,
Barney S. Graham
2Viral Pathogenesis Laboratory
Search for other works by this author on:
Mario Roederer,
Mario Roederer
5ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892
Search for other works by this author on:
Richard A. Koup
Richard A. Koup
1Immunology Laboratory
Search for other works by this author on:
Melissa L. Precopio
1Immunology Laboratory
Michael R. Betts
6Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
Janie Parrino
2Viral Pathogenesis Laboratory
David A. Price
3Human Immunology Section
7Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, England, UK
Emma Gostick
7Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, England, UK
David R. Ambrozak
1Immunology Laboratory
Tedi E. Asher
3Human Immunology Section
Daniel C. Douek
3Human Immunology Section
Alexandre Harari
8Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland
Giuseppe Pantaleo
8Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland
Robert Bailer
4Immunology Core Laboratory
Barney S. Graham
2Viral Pathogenesis Laboratory
Mario Roederer
5ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892
Richard A. Koup
1Immunology Laboratory
CORRESPONDENCE Richard A. Koup: [email protected]
Abbreviations used: APC, allophycocyanin; CCR, CC chemokine receptor; MFI, median fluorescence intensity; MIP, macrophage inflammatory protein; MVA, modified vaccinia virus Ankara.
Received:
November 09 2006
Accepted:
April 25 2007
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2007
J Exp Med (2007) 204 (6): 1405–1416.
Article history
Received:
November 09 2006
Accepted:
April 25 2007
Citation
Melissa L. Precopio, Michael R. Betts, Janie Parrino, David A. Price, Emma Gostick, David R. Ambrozak, Tedi E. Asher, Daniel C. Douek, Alexandre Harari, Giuseppe Pantaleo, Robert Bailer, Barney S. Graham, Mario Roederer, Richard A. Koup; Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses . J Exp Med 11 June 2007; 204 (6): 1405–1416. doi: https://doi.org/10.1084/jem.20062363
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement